Efficacy and Safety of Weekly Dalbavancin Therapy for Catheter-Related Bloodstream Infection Caused by Gram-Positive Pathogens
Clinical Infectious Diseases2005Vol. 40(3), pp. 374–380
Citations Over TimeTop 1% of 2005 papers
Issam Raad, Rabih O. Darouiche, José A. Vázquez, Arnold Lentnek, Ray Hachem, Hend Hanna, Beth P. Goldstein, Tim Henkel, Elyse Seltzer
Abstract
Dalbavancin thus appears to be an effective and well-tolerated treatment option for adult patients with CR-BSIs caused by CoNS and S. aureus, including MRSA.
Related Papers
- → Activities of Dalbavancin In Vitro and in a Rabbit Model of Experimental Endocarditis Due to Staphylococcus aureus with or without Reduced Susceptibility to Vancomycin and Teicoplanin(2004)65 cited
- → Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series(2022)4 cited
- → Comparative In Vitro Activities of Oritavancin, Dalbavancin, and Vancomycin against Methicillin-Resistant Staphylococcus aureus Isolates in a Nondividing State(2016)30 cited
- In vitro induction of resistance in Staphylococcus aureus to vancomycin and the susceptibility of other antibiotics against the vancomycin-resistant S. aureus(2005)